Save your place

Sign in to WhoBought

Please try again later.

BioCryst Pharmaceuticals, Inc. (BCRX) institutional ownership

Latest close $9.51 Jul 22, 2026
Market cap$1.7B 52-week range SectorHealthcare
Funds holding · Q1 2026
295
reported BCRX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
178 buyers · 117 sellers

BioCryst Pharmaceuticals, Inc. (BCRX) price and institutional activity

Dates

Q1 2026

$0 bought by 178 investors
Tcg Crossover Management, LLCVestal Point Capital, LP +176 more
$0 sold by 117 investors
Two Sigma Advisers, LPKynam Capital Management, LP +115 more
Bought Sold Totals per quarter; hover a bar for the names.

BioCryst Pharmaceuticals, Inc. (BCRX) institutional activity · 295

Investor Type Est. change Change Δ Own Date
Tcg Crossover Management, LLC · New
Change +11.0M Date Q1 2026
Tcg Crossover Management, LLC New· Q1 2026 +11.0M Q1 2026
Vestal Point Capital, LP · Added
Change +4.8M Date Q1 2026
Vestal Point Capital, LP Added· Q1 2026 +4.8M Q1 2026
Perceptive Advisors LLC · Added
Change +4.3M Date Q1 2026
Perceptive Advisors LLC Added· Q1 2026 +4.3M Q1 2026
Aberdeen Group PLC · Added
Change +4.1M Date Q1 2026
Aberdeen Group PLC Added· Q1 2026 +4.1M Q1 2026
Two Sigma Advisers, LP · Exited
Change −4.1M Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −4.1M −100.0% Q1 2026
Frazier Life Sciences Management, L.P. · New
Change +4.0M Date Q1 2026
Frazier Life Sciences Management, L.P. New· Q1 2026 +4.0M Q1 2026
Kynam Capital Management, LP · Reduced
Change −3.7M Date Q1 2026
Kynam Capital Management, LP Reduced· Q1 2026 −3.7M Q1 2026
Bank of America Corp · Added
Change +3.6M Date Q1 2026
Bank of America Corp Added· Q1 2026 +3.6M Q1 2026
Rfg Advisory, LLC · New
Change +2.9M Date Q1 2026
Rfg Advisory, LLC New· Q1 2026 +2.9M Q1 2026
Baker Bros. Advisors LP · Exited
Change −2.8M Δ Own −100.0% Date Q1 2026
Baker Bros. Advisors LP Exited· Q1 2026 −2.8M −100.0% Q1 2026
Candriam S.c.a. · New
Change +2.3M Date Q1 2026
Candriam S.c.a. New· Q1 2026 +2.3M Q1 2026
Qube Research & Technologies Ltd · Exited
Change −2.2M Δ Own −100.0% Date Q1 2026
Qube Research & Technologies Ltd Exited· Q1 2026 −2.2M −100.0% Q1 2026
Susquehanna International Group, LLP · Added
Change +2.1M Date Q1 2026
Susquehanna International Group, LLP Added· Q1 2026 +2.1M Q1 2026
Vanguard · Added
Change +2.1M Date Q1 2026
Vanguard Added· Q1 2026 +2.1M Q1 2026
Two Sigma Investments, LP · Added
Change +1.9M Δ Own +41.6% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.9M +41.6% Q1 2026
Data through Q1 2026 · filed Jun 4, 2026
15 of 295

Famous investor activity in BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals, Inc. (BCRX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Milne Jill C. · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Milne Jill C. Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
Galson Steven K. · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Galson Steven K. Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
Levin Alan G. · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Levin Alan G. Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
Frank Steven · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Frank Steven Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
Sanders Machelle · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Sanders Machelle Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
Milano Vincent · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Milano Vincent Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
Stonehouse Jon P. · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Stonehouse Jon P. Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
McKee Amy E. · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
McKee Amy E. Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
Heggie Theresa · Director 2 operations 49K
Owned 34K Trade date Jun 11, 2026 Filed date Jun 15, 2026
Heggie Theresa Director 2 operations 49K 34K Jun 11, 2026 Jun 15, 2026
Milne Jill C. · Director Grant (A) $11K
Price $8.91 Qty 1K Owned 17K Trade date May 29, 2026 Filed date Jun 2, 2026
Milne Jill C. Director Grant (A) $8.91 1K $11K 17K May 29, 2026 Jun 2, 2026
Stonehouse Jon P. · Director Grant (A) $6K
Price $8.91 Qty 631 Owned 1.3M Trade date May 29, 2026 Filed date Jun 2, 2026
Stonehouse Jon P. Director Grant (A) $8.91 631 $6K 1.3M May 29, 2026 Jun 2, 2026
McKee Amy E. · Director Grant (A) $6K
Price $8.91 Qty 631 Owned 32K Trade date May 29, 2026 Filed date Jun 2, 2026
McKee Amy E. Director Grant (A) $8.91 631 $6K 32K May 29, 2026 Jun 2, 2026
Milano Vincent · Director Grant (A) $10K
Price $8.91 Qty 1K Owned 93K Trade date May 29, 2026 Filed date Jun 2, 2026
Milano Vincent Director Grant (A) $8.91 1K $10K 93K May 29, 2026 Jun 2, 2026
Frank Steven · Director Grant (A) $11K
Price $8.91 Qty 1K Owned 20K Trade date May 29, 2026 Filed date Jun 2, 2026
Frank Steven Director Grant (A) $8.91 1K $11K 20K May 29, 2026 Jun 2, 2026
McKee Amy E. · Director Sell −$100K
Price $8.97 Qty −11K Owned 31K Trade date May 18, 2026 Filed date May 19, 2026
McKee Amy E. Director Sell $8.97 −11K −$100K 31K May 18, 2026 May 19, 2026
15 of 57
15 of 57 Sign in to continue to older insider transactions.

BioCryst Pharmaceuticals, Inc. (BCRX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 21.0M
% of shares outstanding 10.2% Filing date Sep 10, 2024
BlackRock Inc. 21.0M 10.2% Sep 10, 2024
Vanguard Group Inc 20.7M
% of shares outstanding 10.0% Filing date Nov 7, 2024
Vanguard Group Inc 20.7M 10.0% Nov 7, 2024
Avoro Capital Advisors LLC 13.1M
% of shares outstanding 6.4% Filing date Feb 14, 2024
Avoro Capital Advisors LLC 13.1M 6.4% Feb 14, 2024
Vanguard Capital Management LLC 13.0M
% of shares outstanding 5.2% Filing date Apr 29, 2026
Vanguard Capital Management LLC 13.0M 5.2% Apr 29, 2026
Baker Bros. Advisors LP 10.1M
% of shares outstanding 4.9% Filing date Feb 14, 2024
Baker Bros. Advisors LP 10.1M 4.9% Feb 14, 2024
State Street Corp 12.2M
% of shares outstanding 4.9% Filing date May 12, 2026
State Street Corp 12.2M 4.9% May 12, 2026
State Street Corp 8.8M
% of shares outstanding 4.3% Filing date Oct 17, 2024
State Street Corp 8.8M 4.3% Oct 17, 2024
7 of 7

BioCryst Pharmaceuticals, Inc. (BCRX) ownership FAQ

Who owns BCRX?

295 reporting institutions disclosed BCRX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.